Skip to main content
# Title Research Year
201 Down-staging after Chemo-radiotherapy for Locally Advanced Rectal Cancer and The approach of Trans-Anal Abdominally Assisted Colo-Anal pull through as a new technique of sphincter preserving for low rectal cancer 2012
202 Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations 2012
203 Effectiveness of combined Botulinum toxin, Electrical stimulation and Rehabilitation on the functional level of spastic arm. 2011
204 Hypofractionation versus conventional fractionation radiotherapy in the adjuvant treatment of early breast cancer : local tumor control and tissue response 2011
205 Hypofractionation versus conventional fractionation radiotherapy in the adjuvant treatment of early breast cancer : local tumor control and tissue response 2011
206 GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. 2011
207 Hypofractionation versus conventional fractionation radiotherapy in the adjuvant treatment of early breast cancer : local tumor control and tissue response 2011
208 Des-gamma Carboxy Prothrombin, Alpha-Feto Protein and Alpha-Feto Protein L3 in Patients with Cirrhosis and Hepatocellular Carcinoma. 2011
209 GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. 2011
210 GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. 2011